Extracellular Matrix News 8.28 July 20, 2017 | |
| |
TOP STORYMelatonin down-regulated gene expression of cyclin D1, PCNA, matrix metallopeptidases-3 and -9 and upregulated gene expression of collagen type II alpha 1 chain and aggrecan in NP cells. The effects of melatonin were blocked by luzindole, a non-specific melatonin membrane receptor antagonist. [J Pineal Res] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Fibulin-4 Deposition Requires EMILIN-1 in the Extracellular Matrix of Osteoblasts By employing confocal immunofluorescence and electron microscopy scientists investigated the localization and extracellular matrix deposition of Elastin-Microfibril-Interface-Located-proteINs (EMILIN)-1 and -2 in tissues of the skeletal system such as cartilage and bone as well as in in vitro cultures of osteoblasts. [Sci Rep] Full Article Researchers report the design and validation of a new methodology for the rapid and accurate production of human acellular liver tissue cubes using normal liver tissue unsuitable for transplantation. [Sci Rep] Full Article The authors created a prevascularized human mesenchymal stem cell (hMSC)/ECM sheet by co-culturing endothelial cells and hMSCs on a nanofibrous ECM scaffold. [J Tissue Eng Regen Med] Abstract Researchers found that triptolide significantly decreased albuminuria and improved glomerulosclerosis in rats with diabetic kidney disease. Triptolide also inhibited ECM protein accumulation and the Notch1 pathway activation under diabetic conditions. [J Cell Physiol] Abstract The authors constructed a tissue-engineered vascular patch using decellularized ECM scaffold obtained from excised human aorta during surgery, which was seeded with patient-derived bone marrow CD34-positive progenitor cells. [Biomed Mater] Abstract It has been suggested that chemoresistance of chondrosarcoma, the cartilage tumor, is caused by the phenotypic microenvironmental features of the tumor tissue, mainly the chondrogenic ECM, and hypoxia. Scientists developed and characterized a multicellular tumor spheroid of human chondrosarcoma HEMC-SS cells to gain insight into tumor cell biology and drug response. [PLoS One] Full Article Investigators examined the impact of ECM proteins on pancreatic ductal adenocarcinoma (PDAC) cancer stem cells. They quantified the effect of ECM proteins, β1-integrin, and focal adhesion kinase (FAK) on clonogenic PDAC growth and migration in vitro and tumor initiation, growth, and metastasis in vivo in nude mice using shRNA and overexpression constructs as well as small molecule FAK inhibitors. [PLoS One] Full Article The biochemical and mechanical properties of bovine articular chondrocytes encapsulated in agarose scaffolds cultured in bioreactors for 21 days were compared to cells statically cultured in agarose scaffolds in addition to static micromass and pellet cultures. [Cell Tissue Res] Abstract Scientists designed an osteogenic ECM coated bioscaffold and applied it to critical bone defect repair with adipose-derived stem cells. [Regen Med] Abstract | Graphical Abstract | |
| |
REVIEWSThe authors review what is known about some of the most studied matricellular proteins and their regulation by hypoxia and redox signaling, as well as the pathological implications of such regulation. [Antioxid Redox Signal] Abstract Researchers describe the important roles of ECM. The representative methods of decellularization and conventional applications of decellularized ECM (dECM) are introduced, followed by the recent achievements in dECM bioinks and their future directions. [Biofabrication] Abstract Visit our reviews page to see a complete list of reviews in the extracellular matrix research field. | |
| |
INDUSTRY NEWSU.S. FDA Designates Mallinckrodt’s StrataGraft® as Regenerative Medicine Advanced Therapy Mallinckrodt plc announced that StrataGraft® regenerative skin tissue is among the first products to be designated as a Regenerative Medicine Advanced Therapy by the FDA under the provisions of the 21st Century Cures Act. [Mallinckrodt plc] Press Release SpinalCyte, LLC Receives New Japanese Patent SpinalCyte, LLC announced the issuance of Japanese Patent No. 6151006, “Methods and Compositions for Repair of Cartilage Using an In Vivo Bioreactor.” [SpinalCyte, LLC (Business Wire Inc.)] Press Release | |
| |
POLICY NEWSSome Scientists Hate NIH’s New Definition of a Clinical Trial. Here’s Why Scientists in behavioral research fields — from cognitive psychology to vision science — were dismayed to learn that the U.S. National Institutes of Health (NIH) in Bethesda, Maryland, could soon deem their studies to be clinical trials. [ScienceInsider] Editorial Salk Institute under Fire for ‘Smear’ on Women Suing It for Discrimination Alleging decades of gender discrimination, two senior female scientists sued the Salk Institute for Biological Studies, sparking a public relations debacle that has engulfed the venerable institution and could threaten its appeal to donors and new researchers. Leaders of the San Diego, California, research center have strenuously denied the allegations made by biologists Vicki Lundblad and Katherine Jones, and publicly questioned their productivity and the quality of their scientific work. [ScienceInsider] Editorial Relatively Few NIH Grantees Get Lion’s Share of Agency’s Funding The rich have been getting richer in the biomedical research enterprise, and the system favors those who are already doing pretty well, according to a new analysis of National Institutes of Health (NIH) grant recipients. [ScienceInsider] Editorial
| |
EVENTSNEW 6th Annual International Symposium on Regenerative Rehabilitation Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Researcher – Systems Microscopy of Cancer Cell Migration (Karolinska Institutet) PhD Studentship – Collagen Based Scaffolds (Swansea University) Postdoctoral Research Associate – Cartilage Biology (University of Nebraska) Postdoctoral Fellow – Mechanobiology of Tissue Repair (St. Michael’s Hospital) Assistant Professor – Stem Cell and Regenerative Biology (Harvard University) Postdoctoral Fellowship – Tissue Fibrosis (University of California, San Francisco) Postdoctoral Fellow – Proteoglycan Remodeling (University of Alberta) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Extracellular Matrix News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|